Why p-OMe- and p-Cl-β-Methylphenethylamines Display Distinct Activities upon MAO-B Binding by Fierro, Angélica et al.
RESEARCH ARTICLE
Why p-OMe- and p-Cl-β-Methylphenethylamines
Display Distinct Activities uponMAO-B Binding
Angélica Fierro1☯, Dale E. Edmondson2☯, Cristian Celis-Barros3*, Marco Rebolledo-
Fuentes4☯, Gerald Zapata-Torres5*
1 Facultad de Química, Departamento de Química Orgánica, Pontificia Universidad Católica de Chile,
Santiago, Chile, 2 Departments of Chemistry and Biochemistry, Emory University, Atlanta, GA, United States
of America, 3 Universidad Andres Bello, Facultad de Ciencias Exactas, Departamento de Ciencias
Quimicas, Santiago, Chile, 4 Department of Chemistry, Faculty of Sciences, University of Chile, Santiago,
Chile, 5 Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile
☯ These authors contributed equally to this work.
* gzapata@uchile.cl
Abstract
Despite their structural and chemical commonalities, p-chloro-β-methylphenethylamine and
p-methoxy-β-methylphenethylamine display distinct inhibitory and substrate activities upon
MAO-B binding. Density Functional Theory (DFT) quantum chemical calculations reveal
that β-methylation and para-substitution underpin the observed activities sustained by cal-
culated transition state energy barriers, attained conformations and key differences in their
interactions in the enzyme’s substrate binding site. Although both compounds meet sub-
strate requirements, it is clear that β-methylation along with the physicochemical features of
the para-substituents on the aromatic ring determine the activity of these compounds upon
binding to the MAO B-isoform. While data for a larger set of compounds might lend general-
ity to our conclusions, our experimental and theoretical results strongly suggest that the
contrasting activities displayed depend on the conformations adopted by these compounds
when they bind to the enzyme.
Introduction
The biogenic amine levels in human cells are controlled in part by their oxidation by ubiqui-
tous enzymes known as monoamine oxidases (MAOs). Since the discovery of the antidepres-
sant activities of certain molecules acting as MAO inhibitors (MAOi) around 1950 [1], these
enzymes have been associated with neurological and neurodegenerative pathologies such as
depression, Parkinson’s and Alzheimer’s diseases [2]. These enzymes, inserted in the outer
membrane of mitochondria, use flavin adenine dinucleotide (FAD) as a cofactor [3]. Even
though the clinically most relevant endogenous substrates of MAOs are serotonin (5-HT) and
dopamine (DA), these enzymes are able to oxidize other monoamines such as benzylamine
(BA), phenylethylamine (PEA) and their derivatives [4–8]. Human MAO exists in two iso-
forms, known as A and B, sharing ca. 70% of sequence identity. Although several MAO crystal
structures are available [9–22], the mechanisms of selectivity regarding substrates and inhibi-
tors for each isoform have not yet reached a consensus. New insights regarding the possible
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catalytic mechanisms for the oxidative deamination of neurotransmitter amines by mono-
amine oxidase B have recently become available [23–26]. Earlier investigations focused largely
on the active site of MAOs, located in a cavity lined mainly by hydrophobic residues [27, 28]. A
special sector of this active site consists of the so-called “aromatic cage” which contains the
FAD cofactor and two tyrosine residues with their rings perpendicular to the isoalloxazine
moiety of FAD. It is known that many MAO substrates become inhibitors when they are α-
methylated, and most of these products inhibit MAO-A selectively. In contrast, β-methylation
of MAO substrates often generates selective MAO-B inhibitors [29]. Almost 30 years ago,
Kinemuchi et al. [30] studied 5-fluoro-α-methyltryptamine (5-FMT) and p-chloro-β-methyl-
phenethylamine (p-CMP). These authors found that both molecules act as selective and revers-
ible inhibitors of MAO-A and MAO-B, respectively. Later results by Kim et al. [31] confirmed
that p-CMP was a short-acting, probably reversible, MAO-B selective inhibitor. In this article,
we report the interesting change in the biological activity displayed by a couple of β-methylphe-
nylalkylamines, where the inhibitor p-CMP becomes a substrate when a methoxyl group
replaces its para-chloro substituent.
Materials and Methods
Biological evaluation
MAO-B was expressed in Pichia pastoris and purified as described previously by Newton-Vin-
son et al. [32] The final step in the preparation of MAO-B used 50 mM potassium phosphate
buffer pH 7.4, 50% glycerol, and 0.8% n-octyl-β-d-glucopyranoside (w/v). MAO activity assays
were performed by monitoring the rate of product formation over time at 25°C using a Perkin-
Elmer Lambda 2 spectrophotometer. p-Methoxy-β-methylphenethylamine oxidation was
monitored spectrometrically using the horseradish peroxidase-coupled Amplex Red assay
(Δε = 54 000 M−1•cm−1, λ = 560 nm). A similar experiment was carried out with kynuramine
(Δε = 12 000 M-1•cm−1, λ = 316 nm) to obtain a control value by monitoring its oxidation.
General methods
1H and 13C NMR spectra were recorded on a Bruker Avance 500 MHz spectrometer at 300 K.
Coupling constants in Hz were measured from-one dimensional spectra. HRMS-ESI analyses
were carried out using a Thermo Scientific Exactive Plus Orbitrap spectrometer with a constant
nebulizer temperature of 250°C. The experiment was carried out in positive ion mode at high
resolution (resolving power: 140,000 (full width half-maximum peak width at m/z 300, Rfwhm).
The samples were infused directly into the ESI source using a syringe pump at flow rates of
5 μL min-1. All chemicals were reagent grade and used without further purification (S1 Fig).
2-(4-Methoxyphenyl)propan-1-aminium chloride. 1 g (0,006 mol) of 4-methoxynitros-
tyrene was dissolved in 50 mL of dry tetrahydrofuran (THF). To this solution, a mixture of 6
mL of a 3 M solution of methylmagnesium bromide (CH3MgBr) in diethyl ether was added
(3:1 ratio), stirring overnight at room temperature. Silica gel column and thin layer chromatog-
raphy (9:1 ethanol:methanol) were used to purify the main product. Once separated, the sol-
vent was removed using a rotary evaporator and the product weighed. This intermediate,
dissolved in dry THF, was slowly added to a suspension of lithium aluminium hydride
(LiAlH4; 1:1 in mass), and the mixture was refluxed overnight. Once the reduction was com-
plete, drops of saturated aqueous sodium hydroxide (NaOH) and isopropyl alcohol (IPA) were
added to form a solid cake that was then washed with THF and filtered. The solvent (mainly
THF) fraction was concentrated as before, and the amine residue was distilled (190°C at 10
Torr). The distilled product was neutralized using a saturated solution of hydrochloric acid in
methanol to obtain a white solid (43% overall yield). 1H NMR (400 MHz, MeOH-d4) δ 7.25 (d,
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J = 8.4 Hz, 2H), 6.95 (d, J = 8.4 Hz, 2H), 3.80 (s, 3H), 3.162 (m, 2H), 3.02 (m, 1H), 1.34 (d,
J = 6.4 Hz, 3H). 13C NMR (125 Hz, MeOH-d4, 300 K): δ 159.13, 133.54, 127.89, 114.15 (ArC),
δ 54.37 (OCH3), δ 47.63 (CH2NH2), δ 37.36 (CH), δ 18.64 (CH3) ppm. HRMS for C10H16NO
[M-Cl]+ m/z Calcd: 166.1226. Observed: 166.1223 (S2 Fig).
Theoretical calculations
To obtain structural and energetic information regarding the MAO-B/p-CMP and MAO-B/p-
MMP complexes, we applied the quantum chemical cluster approach for modeling enzyme
reactions. This methodology considers a selected part of the enzyme (ca. 229 atoms for p-
CMP, 233 atoms for p-MMP) provided that this small cluster behaves like the real system (S3
and S4 Figs), taking into account two the steric constraints imposed by the enzyme on the
active site and long-range polarization effects. Steric constraints consider all the side chain Cαs
of the cluster residues for MAO-B as locked into their crystallographic positions. Long range
polarization effects take into account solvation effects using the CPCM conductor-like polariz-
able continuum model [33,34] with two dielectric constants, i.e. ε = 4 and ε = 80, performing
single-point calculations on the optimized structures. The strength of this methodology makes
the cluster selection independent of the dielectric constant [35]. Cluster selection was carried
out using the crystal structure of human MAO-B expressed in Pichia pastoris complexed with
p-nitrobenzylamine (NBA) (PDB code 2C70) [22]. NBA is bound to the binding site with its
side chain pointing towards the FAD cofactor. Since no crystal structures are available for p-
CMP and p-MMP, the pose adopted by NBA was used to locate their aromatic moieties. The
active site models included the isoalloxazine ring, Tyr398 and Tyr435, Tyr188, Gln206, Lys296,
Cys172, Ile199 and Tyr326 and six water molecules present in this crystal structure, further
verified by the WaterDock [36] script in the Vina Docking program.
All calculations were carried out using the meta-hybrid GGA functional M06-2X [37]
implemented in the Gaussian09 suite of programs [38]. Geometries were optimized using the
6-31G(d,p) basis set. In order to get more accurate energies, single-point calculations were car-
ried out on the optimized geometries using the larger 6–311+G(2d,2p) basis set. Frequencies
were computed analytically at the same level of theory as the geometry optimizations to con-
firm whether the obtained structures were minima or transition states and to obtain zero-point
energy (ZPE) corrections. The final reported energies consist of the large basis set energies cor-
rected for ZPE, solvation, and dispersion effects. In order to unequivocally assign reactants and
products we scaled the transition state frequencies, which then were optimized and confirmed
as local minima. Imaginary frequencies of the enzymatic transition states were -1153.3, and
-1048.8 cm-1 for p-CMP and p-MMP, respectively.
The reaction rate constant (k) can be expressed as:
k ¼ kbT
h
e
DG 6¼
RT ð1Þ
For enzymatic reactions, the calculated reaction barrier can be compared with the experi-
mental kinetic results, provided kcat is available. Thus, the experimental Gibbs free energy bar-
rier was obtained from kinetic rate constants using Eq 2.
DG 6¼exp ¼ RTln
kh
kbT
 
ð2Þ
where k = rate constant; kb = Boltzmann constant; T = temperature; ΔG
6¼ = free energy of acti-
vation; h = Planck’s constant; R = gas constant. This equation is valid for simple transition
state theory where the transmission coefficient is approximated to unity [39].
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NCIPLOT software was used to understand the anchoring of the studied compounds at the
active site. This program calculates the NCI indexes, which are based on the reduced density
gradient defined as s(ρ) (Eq 3) at low densities and accounting for non-covalent interactions
such as van der Waals, steric clashes and hydrogen bonds.
s ¼ 1
2ð3p2Þ1=3
rr
r4=3
ð3Þ
In order to recognize the nature of the non-bonded interactions, the sign of the second
eigenvalue (λ2) of the Laplacian of the density is related to: 1) hydrogen bonds if λ2< 0, 2) ste-
ric repulsion if λ2> 0 and 3) van der Waals interactions if λ2 0. Therefore, ρsign(λ2)
ranges from negative to positive values and the density itself is used to evaluate the strength of
the interaction [40,41]. Analysis of NCI peaks is needed to differentiate between interaction
types. The sign of the Laplacian of the density (r2ρ) indicates whether the net gradient flux is
entering (r2ρ< 0) or leaving (r2ρ> 0) an infinitesimal volume around a reference point.
Hence, it highlights whether the density is concentrated or depleted at that point, relative to
the surrounding environment [42].
Results and Discussion
In order to study the influence of the para-substituent on the activity of β-methylphenylalkyla-
mines, we prepared p-methoxy-β-methylphenethylamine (p-MMP) where the chlorine atom is
replaced by a sterically similar methoxyl group on the aromatic ring. As mentioned before, Kine-
muchi et al. and Kim et al. [30, 31] found that p-CMP was a highly selective MAO-B-inhibitor.
However, we found that its p-methoxyl counterpart behaves like a selective substrate, with a low
kcat of 14 min
-1 and a Michaelis constant of 87 μM compared to phenylethylamine (PEA) which
is described as a good MAO-B substrate (Kcat 300 min
-1 and Km 0.016 mM) [21]. According to
these experimental results, we hypothesize that the nature of the para-substituent determines the
agonist or antagonist character displayed by these substrate analogues with MAO-B. Table 1
shows that p-chlorophenethylamine (p-CP), as a model of compounds lacking the β-methyl
group, is a poor substrate with a Kcat of 3.41 min
-1, and β-methylation (as in the case of p-CMP)
turns this molecule into an inhibitor (Ki = 0.55 μM) as reported by Kinemuchi et al. [30]
We modelled the rate-determining step and calculated the reactant, transition state and
product energies and free Gibbs energy barriers for the MAO-B/p-CMP and MAO-B/p-MMP
complexes (S1 Table). All states were confirmed as ground or transition states according to
their calculated frequencies. Our results show that the p-chloro derivative displays a higher
activation energy compared to its p-methoxylated counterpart (35 kcal/mol vs 19.5 kcal/mol).
Table 1. p-CMP and p-MMP kinetic constants for MAO-B and experimental and calculated free Gibbs energy barriers.
Molecule Ki (μM) kcat (min-1) Km (μM) ΔG‡expe (kcal/mol) ΔG‡theoe (kcal/mol)
PEA N.D. 228 ± 0.9a 16 ± 1a 16.7b 17.1b
p-CPc N.D. 3.41 ± 0.12 2.4 ± 0.2 19.15 N.C.
p-CMP 0.55d N.D. N.D. N.D. 35.0
p-MMP N.D. 14 ± 1 87 ± 8 18.3 19.5
a Constants reported by Li et al. [21].
b Constants reported by Zapata et al. [23].
c Constants reported by Heuson et al. [43].
d Constants reported by Kinemuchi et al. [30].
e See Electronic Supplementary Information. N.D. = Not Determined. N.C. = Not Calculated.
doi:10.1371/journal.pone.0154989.t001
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The lower energy barrier displayed by p-MMP is in agreement with the obtained experimental
value of 18.3 kcal/mol (Table 1). It is worth mentioning that energy barriers higher than 25
kcal/mol make enzyme catalysis very unlikely [44]. Also, NCI (non-covalent interaction)
indexes were evaluated to provide information regarding weak ligand-enzyme interactions
based on the reduced density gradient in low-density regions [40–42]. These interactions are
important since they govern, not only the anchorage, but also the stabilization of the substrate
orientations at the binding site. Inspection of the obtained TS geometries of both complexes
(Fig 1) shows that the bound p-CMP ring is rotated by ca. 60° with respect to that of p-MMP.
This conformation is best explained by the non-covalent interactions established in the
active site by p-CMP. Also, taking into account the anisotropic electronic distribution on the
chlorine atom [45], the generation of a positive σ hole at the far end of the C-Cl bond allows a
specific and orthogonal hydrogen bond to form. Specifically, a weak hydrogen bond can be
seen between the chlorine atom of p-CMP and the amide moiety of Cys172 (S5 Fig). Fig 1
shows that the prevailing interactions for p-CMP are van der Waals in nature according to the
NCI indexes (light green coloured).
On the other hand, the methoxyl oxygen atom of p-MMP also interacts with the thiol
hydrogen of Cys172; however, its methyl group is located opposite to the position of the chlo-
ride atom of p-CMP (Fig 1B and 1D, and S6 Fig).
The differences described above are directly related to the interactions established in the
reactive region of the TS structures, which comprises N5 and C4a of FAD, and the amine nitro-
gen (Nam), Cα and Hα of the substrate (Fig 2). In Fig 1A and 1C it can be seen that p-MMP
displays stronger interactions than p-CMP. Specifically, p-MMP exhibits a strong hydrogen
bond between O4 of FAD and a conserved water molecule linking FAD to Lys296.
This water molecule has been reported to be important in catalysis, stabilising the TS by
linking Lys296 to FAD [23]. Additionally, we note that both p-CMP and p-MMP display an
interaction between Nam and C4a of the flavin, which has been suggested to occur in the polar
nucleophilic mechanism (S7 Fig) [23]. Also, it should be emphasized that the TS of p-MMP is
stabilized by a strong hydrogen bonding network of water molecules, which in the case of p-
CMP is almost absent (Fig 3). This loss of hydrogen bonding interactions explains the calcu-
lated difference in the activation energies of both molecules (ca. 15 kcal/mol).
Our findings indicate that β-methyl substitution on phenethylamines allows substrates to
adopt a suitable orientation to undergo catalysis; i.e. leaving the pro-R Hα pointing towards
N5 of FAD. However, the other interactions established only by p-MMP allow the proper ori-
entation of its aromatic ring parallel to the two tyrosine residues of the aromatic cage, thus
mimicking other MAO-B substrates [23]. Therefore, conformational constraints imposed by
β-methylation in combination with the restricted interaction displayed by the p-chlorine sub-
stituent and the breaking of the water network place p-CMP in the substrate pocket but with
features that do not allow the oxidation to occur. These results are in agreement with previous
conclusions of Edmondson et al. [46] who argue that the para-position of the bound substrate
is in a hydrophobic domain of limited size. With these restrictions, bound p-MMP can adopt
an orientation that favors its substrate character.
Conclusions
In conclusion, although both p-CMP and p-MMP meet the structural requirements for
MAO-B substrates, it is clear that the combined presence of a β-methyl group and para-substit-
uents of similar volume but different electronic properties on the aromatic ring, determines the
agonist or antagonist activity of these compounds. While experimental data for a larger set of
compounds would most likely enrich this discussion, our experimental and theoretical results
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Fig 1. Non-covalent interaction (NCI) surface for binding site models in TS complexes with p-CMP and p-MMP after QM optimization. Red
squares indicate hydrogen bonds (blue surfaces) and favorable van der Waals interactions (light green surfaces). a) the reactive region of p-CMP; b)
p-substituent region of p-CMP, c) the reactive region of p-MMP and d) p-substituent region of p-MMP. p-CMP is depicted in cyan ball and sticks while
p-MMP is depicted in yellow ball and sticks. NCI indexes isovalues range from 0.035 to -0.035 (au). p-MMP (p-methoxy-β-methylphenylethylamine);
p-CMP (p-chloro-β-mehtylphenylethylamine), respectively.
doi:10.1371/journal.pone.0154989.g001
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strongly suggest that the different activities displayed by these two very similar compounds
depends on the conformation they can adopt upon binding in the MAO-B catalytic site.
Supporting Information
S1 Fig. HRMS-ESI spectrum.HRMS-ESI analyses were carried out by using a Thermo Scien-
tific Exactive Plus Orbitrap spectrometer with a constant nebulizer temperature of 250° C. The
experiment was carried out in positive ion mode at high resolution (resolving power: 140,000
(full width half-maximum peak width atm/z 300, Rfwhm). The samples were infused directly
into the ESI source using a syringe pump at flow rates of 5 μL min-1.
(PDF)
S2 Fig. Plots of 1H and 13C NMR spectra.
(PDF)
S3 Fig. Cluster considered for the transition state structure for p-CMP. Atoms and bonds
are depicted as balls and sticks. p-CMP in cyan. All other atoms are depicted as follows: carbon
Fig 2. Structure and nomenclature. a) isoalloxazine ring of FAD. b) p-CMP or p-MMP.
doi:10.1371/journal.pone.0154989.g002
Fig 3. Hydrogen bond network. In a) p-CMP and b) p-MMP at the active site of MAO-B.
doi:10.1371/journal.pone.0154989.g003
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atoms in grey, oxygen atoms in red, nitrogen atoms in blue and hydrogen atoms in white.
(PDF)
S4 Fig. Cluster considered for the transition state structure for p-MMP. Atoms and bonds
are depicted as balls and sticks. p-MMP in yellow. All other atoms are depicted as follows: car-
bon atoms in grey, oxygen atoms in red, nitrogen atoms in blue and hydrogen atoms in white.
(PDF)
S5 Fig. Full NCI indexes of the transition state of p-CMP at the active site. NCI indexes col-
oured ranging from 0.035 to -0.035 (au). For the sake of clarity some amino acid side-chains
have been deleted from the figure.
(PDF)
S6 Fig. Full NCI indexes of the transition state of p-MMP at the active site. NCI indexes iso-
values coloured ranging from 0.035 to -0.035 (au). For the sake of clarity some amino acid
side-chains have been deleted from the figure.
(PDF)
S7 Fig. Proposed polar nucleophilic mechanism. This mechanism involves a proton transfer
by means of a Nam-C4a adduct.
(PDF)
S1 Table. Calculated contributions to free energy of activation for p-CMP and p-MMP
complexed with MAO-B.
(PDF)
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